BRD8518 is a PCSK9 inhibitor (EC50=0.23 µM). BRD8518 lowers blood lipids by upregulating LDLR expression and stimulating LDL uptake. BRD8518 can be used in the study of cardiovascular diseases[1].
Molecular Weight:
607.62
CAS Number:
[1565828-01-4]
Formula:
C33H32F3N3O5
Target:
LDLR,PCSK9
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted